Literature DB >> 26723138

C9orf72 repeat expansions that cause frontotemporal dementia are detectable among patients with psychosis.

Annie Watson1, Mochtar Pribadi2, Kodavali Chowdari1, Sue Clifton1, Bruce L Miller3, Giovanni Coppola4, Vishwajit Nimgaonkar5.   

Abstract

A pathologic hexanucleotide repeat expansion in C9orf72 causes frontotemporal dementia (FTD) or amyotrophic lateral sclerosis (ALS). Behavioral abnormalities can also occur among mutation carriers with FTD, but it is uncertain whether such mutations occur among persons with psychoses per se. Among participants in a genetic study of psychoses (N=739), two pairs of related individuals had C9orf72 expansions, of whom three were diagnosed with schizophrenia (SZ) / schizoaffective disorder (SZA), but their clinical features did not suggest dementia or ALS. A few patients with SZ/SZA carry C9orf72 repeat expansions; such individuals are highly likely to develop FTD/ALS.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Dementia; Schizoaffective disorder; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26723138      PMCID: PMC4724461          DOI: 10.1016/j.psychres.2015.12.007

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

Review 2.  Advances in understanding the molecular basis of frontotemporal dementia.

Authors:  Rosa Rademakers; Manuela Neumann; Ian R Mackenzie
Journal:  Nat Rev Neurol       Date:  2012-06-26       Impact factor: 42.937

Review 3.  Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum.

Authors:  Marc Cruts; Ilse Gijselinck; Tim Van Langenhove; Julie van der Zee; Christine Van Broeckhoven
Journal:  Trends Neurosci       Date:  2013-06-07       Impact factor: 13.837

4.  Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability.

Authors:  Malcolm Proudfoot; Nick J Gutowski; Dieter Edbauer; David A Hilton; Mark Stephens; Julia Rankin; Ian R A Mackenzie
Journal:  Acta Neuropathol       Date:  2014-01-21       Impact factor: 17.088

5.  C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia.

Authors:  Daniela Galimberti; Andreas Reif; Bernardo Dell'osso; Sarah Kittel-Schneider; Christine Leonhard; Alexandra Herr; Carlotta Palazzo; Chiara Villa; Chiara Fenoglio; Maria Serpente; Sara M G Cioffi; Cecilia Prunas; Riccardo A Paoli; A Carlo Altamura; Elio Scarpini
Journal:  Neurobiol Aging       Date:  2013-12-11       Impact factor: 4.673

6.  Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.

Authors:  Jon Beck; Mark Poulter; Davina Hensman; Jonathan D Rohrer; Colin J Mahoney; Gary Adamson; Tracy Campbell; James Uphill; Aaron Borg; Pietro Fratta; Richard W Orrell; Andrea Malaspina; James Rowe; Jeremy Brown; John Hodges; Katie Sidle; James M Polke; Henry Houlden; Jonathan M Schott; Nick C Fox; Martin N Rossor; Sarah J Tabrizi; Adrian M Isaacs; John Hardy; Jason D Warren; John Collinge; Simon Mead
Journal:  Am J Hum Genet       Date:  2013-02-21       Impact factor: 11.025

7.  C9ORF72 repeat expansions not detected in a group of patients with schizophrenia.

Authors:  Edward D Huey; Peter L Nagy; Laura Rodriguez-Murillo; Masood Manoochehri; Jill Goldman; Jeffrey Lieberman; Maria Karayiorgou; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

8.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

Review 9.  Frontotemporal dementia presenting as schizophrenia-like psychosis in young people: clinicopathological series and review of cases.

Authors:  D Velakoulis; M Walterfang; R Mocellin; C Pantelis; C McLean
Journal:  Br J Psychiatry       Date:  2009-04       Impact factor: 9.319

10.  Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample.

Authors:  Ciara Fahey; Susan Byrne; Russell McLaughlin; Kevin Kenna; Aleksey Shatunov; Gary Donohoe; Michael Gill; Ammar Al-Chalabi; Daniel G Bradley; Orla Hardiman; Aiden P Corvin; Derek W Morris
Journal:  Neurobiol Aging       Date:  2013-12-12       Impact factor: 4.673

View more
  8 in total

Review 1.  Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms.

Authors:  Hannah E Silverman; Jill S Goldman; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-26       Impact factor: 5.081

2.  The Confluence of Psychiatric Symptoms and Neurodegenerative Disease: Impact on Genetic Counseling.

Authors:  Jill S Goldman; Edward D Huey; Deborah Z Thorne
Journal:  J Genet Couns       Date:  2016-12-24       Impact factor: 2.537

3.  C9orf72 hexanucleotide repeat expansions are not a common cause of obsessive-compulsive disorder.

Authors:  Karissa C Arthur; Alberto M Rivera; Jack Samuels; Ying Wang; Marco Grados; Fernando S Goes; Brion Maher; Gerald Nestadt; Bryan J Traynor
Journal:  J Neurol Sci       Date:  2017-01-12       Impact factor: 3.181

4.  Psychiatric symptoms in preclinical behavioural-variant frontotemporal dementia in MAPT mutation carriers.

Authors:  Gayathri Cheran; Hannah Silverman; Masood Manoochehri; Jill Goldman; Seonjoo Lee; Liwen Wu; Sarah Cines; Emer Fallon; Brendan Desmond Kelly; Diana Angelika Olszewska; Judith Heidebrink; Sarah Shair; Stephen Campbell; Henry Paulson; Timothy Lynch; Stephanie Cosentino; Edward D Huey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-01-20       Impact factor: 10.154

Review 5.  Bipolar Disorder Among Patients Diagnosed With Frontotemporal Dementia.

Authors:  Mario F Mendez; Leila Parand; Golnoush Akhlaghipour
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2020-06-05       Impact factor: 2.198

6.  Clinical Update on C9orf72: Frontotemporal Dementia, Amyotrophic Lateral Sclerosis, and Beyond.

Authors:  Dario Saracino; Isabelle Le Ber
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Subacute combined degeneration of the spinal cord masking motor neuron disease: a case report.

Authors:  Paula Loveland; Aaron Wong; Vinojini Vivekanandam; Wen Kwang Lim
Journal:  J Med Case Rep       Date:  2019-11-18

Review 8.  Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders.

Authors:  Simon Ducharme; Annemiek Dols; Robert Laforce; Emma Devenney; Fiona Kumfor; Jan van den Stock; Caroline Dallaire-Théroux; Harro Seelaar; Flora Gossink; Everard Vijverberg; Edward Huey; Mathieu Vandenbulcke; Mario Masellis; Calvin Trieu; Chiadi Onyike; Paulo Caramelli; Leonardo Cruz de Souza; Alexander Santillo; Maria Landqvist Waldö; Ramon Landin-Romero; Olivier Piguet; Wendy Kelso; Dhamidhu Eratne; Dennis Velakoulis; Manabu Ikeda; David Perry; Peter Pressman; Bradley Boeve; Rik Vandenberghe; Mario Mendez; Carole Azuar; Richard Levy; Isabelle Le Ber; Sandra Baez; Alan Lerner; Ratnavalli Ellajosyula; Florence Pasquier; Daniela Galimberti; Elio Scarpini; John van Swieten; Michael Hornberger; Howard Rosen; John Hodges; Janine Diehl-Schmid; Yolande Pijnenburg
Journal:  Brain       Date:  2020-06-01       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.